In a genome‐wide CRISPR‐Cas9‐based genetic screening study carried out with the GeCKO library in two bladder cancer cell lines, MSH2, MLH1, FAM89B, XPC and PMS2 were identified as the top five candidate genes. The gene discussed is MLH1; the disease is urinary bladder carcinoma.